Odyssey Health (ODYY) Total Non-Current Liabilities (2019 - 2026)

Odyssey Health's (ODYY) quarterly Total Non-Current Liabilities came in at -$2.1 million in Q2 2026, up 36.02% quarter-over-quarter from -$3.2 million in Q1 2026.

Odyssey Health (ODYY) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Odyssey Health's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at -$2.1 million for Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to -$2.1 million in Q2 2026; TTM through Apr 2026 was -$2.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $49723.0, changed N/A from the prior year.
  • Total Non-Current Liabilities climbed to -$2.1 million in Q2 2026 per ODYY's latest filing, from -$3.2 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $49723.0 in Q3 2025 and bottomed at -$3.2 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Odyssey Health 1.08 Mn 782,508.17 - -2.06 Mn

Historic Data

Download Data
DateValue
Apr 30, 2026 -2.06 Mn
Jan 31, 2026 -3.21 Mn
Oct 31, 2025 -81,533.00
Jul 31, 2025 49,723.00
Apr 30, 2020 1.36 Mn
Jan 31, 2020 1.19 Mn
Oct 31, 2019 1.07 Mn
Jul 31, 2019 986,203.00